XML 79 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stockholders' Equity
12 Months Ended
Dec. 31, 2014
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
Note 5. Stockholders’ Equity
Our authorized, issued, and outstanding shares (stated in whole numbers) at year end consist of the following:
 
Par Value
 
2014
 
2013
Preferred stock
.01/share
 
 
 
 
Shares authorized
 
 
5,000,000

 
5,000,000

Shares issued and outstanding
 
 

 

Common stock
.01/share
 
 
 
 
Shares authorized
 
 
400,000,000

 
400,000,000

Shares issued and outstanding
 
 
295,867,844

 
296,753,544


Dividends
On January 14, 2015, our board of directors declared a quarterly dividend of $0.28 per share of common stock to be paid in cash on February 27, 2015 to shareholders of record at the close of business on January 30, 2015. We paid aggregate annual dividends per share of $1.00, $0.80, and $1.24 in 2014, 2013, and 2012, respectively. The 2012 amount included a fourth quarter supplemental dividend of $0.50.
Stock Purchases
On January 14, 2015, our board of directors increased the maximum number of shares of our common stock that may yet be purchased to 2,000,000 shares.
Stock Options
The following tables summarize the details of grants made under our stock option plan that are still outstanding, and the assumptions used to value these grants. All options granted were effective at the close of business on the date of grant.
 
  
Options
Granted
 
Option Exercise
(Strike) Price
 
Closing Stock
Price on Date
of Grant
 
December 31, 2014
Date of Grant
Options
Outstanding
 
Options
Exercisable
April 22, 2014
955,000

 
$
56.00

 
$
50.53

 
852,500

 

April 16, 2013
205,000

 
$
54.00

 
$
49.25

 
155,000

 

April 17, 2012
1,235,000

 
$
54.00

 
$
49.01

 
1,077,500

 
243,750

April 19, 2011
410,000

 
$
35.00

 
$
31.78

 
320,000

 
60,000

April 20, 2010
530,000

 
$
30.00

 
$
27.13

 
237,300

 
102,300

April 21, 2009
790,000

 
$
27.00

 
$
17.61

 
345,600

 
199,350

April 15, 2008
550,000

 
$
27.00

 
$
24.35

 
172,500

 
117,500

April 17, 2007
4,380,000

 
$
22.50

 
$
20.15

 
1,551,930

 
1,249,430

Total
9,055,000

 
 
 
 
 
4,712,330

 
1,972,330

 
Date of Grant
Risk-free
Interest Rate
 
Expected Life
of Option in
Years
 
Expected
Dividend
Yield
 
Expected
Stock
Volatility
 
Estimated Fair
Value of Stock
Option
April 22, 2014
1.8
%
 
5.00
 
2.0
%
 
28.55
%
 
$
9.57

April 16, 2013
0.7
%
 
5.00
 
1.6
%
 
37.42
%
 
$
12.66

April 17, 2012
0.9
%
 
5.00
 
1.4
%
 
39.25
%
 
$
13.69

April 19, 2011
2.1
%
 
5.00
 
1.6
%
 
39.33
%
 
$
11.20

April 20, 2010
2.6
%
 
5.00
 
1.5
%
 
39.10
%
 
$
8.14

April 21, 2009
1.9
%
 
5.00
 
1.0
%
 
38.80
%
 
$
3.64

April 15, 2008
2.7
%
 
5.00
 
1.0
%
 
30.93
%
 
$
7.75

April 17, 2007
4.6
%
 
4.85
 
1.0
%
 
31.59
%
 
$
5.63


All of the options in the tables above vest and become exercisable over a period of up to eight years. Each option will terminate approximately nine years after the grant date.
The fair value of each share-based option is estimated on the date of grant using a Black-Scholes valuation method that uses the assumptions listed above. The risk-free interest rate is based on the U.S. Treasury rate over the expected life of the option at the time of grant. The expected life is the average length of time over which we expect the employee groups will exercise their options, which is based on historical experience with similar grants. The dividend yield is estimated over the expected life of the option based on our current dividend payout, historical dividends paid, and expected future cash dividends. Expected volatilities are based on the movement of our stock over the most recent historical period equivalent to the expected life of the option.
A summary of the activity under our stock option plan is as follows:
 
Options
Outstanding
 
Exercise
Price1
 
Remaining
Life2
Outstanding as of January 1, 2014
4,356,630

 
$
34.06

 
4.66
Granted
955,000

 
$
56.00

 
8.41
Exercised
(314,300
)
 
$
24.49

 
 
Cancelled/forfeited
(285,000
)
 
$
44.39

 
 
Outstanding as of December 31, 2014
4,712,330

 
$
38.52

 
4.59
Exercisable as of December 31, 2014
1,972,330

 
$
27.89

 
2.51
 
 
Options
Outstanding
 
Exercise
Price1
 
Remaining
Life2
Outstanding as of January 1, 2013
4,835,792

 
$
32.51

 
5.40
Granted
205,000

 
$
54.00

 
8.41
Exercised
(389,162
)
 
$
23.91

 
 
Cancelled/forfeited
(295,000
)
 
$
35.89

 
 
Outstanding as of December 31, 2013
4,356,630

 
$
34.06

 
4.66
Exercisable as of December 31, 2013
1,442,380

 
$
23.61

 
2.74
1 
Weighted average exercise price
2 
Weighted average remaining contractual life in years
The total intrinsic value of stock options exercised during the years ended December 31, 2014, 2013, and 2012 was $7,466, $9,925, and $34,424, respectively. The intrinsic value represents the difference between the exercise price and fair value of the underlying shares at the date of exercise.
At December 31, 2014, there was $15,908 of total unrecognized compensation cost related to unvested stock options granted under the plan. This cost is expected to be recognized over a weighted average period of 4.60 years. The total grant date fair value of options vested under our stock option plan during 2014, 2013, and 2012 was $7,287, $3,508, and $3,866, respectively.
Total stock-based compensation expense related to our stock option plan was $7,039, $5,400, and $4,800 for 2014, 2013, and 2012, respectively.
Earnings Per Share
The following tables present a reconciliation of the denominators used in the computation of basic and diluted earnings per share and a summary of the options to purchase shares of common stock which were excluded from the diluted earnings calculation because they were anti-dilutive:
Reconciliation
2014
 
2013
 
2012
Basic weighted average shares outstanding
296,490,378

 
296,754,160

 
296,089,348

Weighted shares assumed upon exercise of stock options
822,866

 
929,428

 
1,061,602

Diluted weighted average shares outstanding
297,313,244

 
297,683,588

 
297,150,950


Summary of Anti-dilutive Options Excluded
2014
 
2013
 
2012
Options to purchase shares of common stock
1,903,767

 
1,273,527

 
847,254

Weighted average exercise prices of options
$
54.67

 
54.00

 
54.00


Any dilutive impact summarized above would relate to periods when the average market price of our stock exceeded the exercise price of the potentially dilutive options then outstanding.